Anbio Biotechnology
N3B
Company Profile
Business description
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. IVD products are designed to detect a wide range of biomarkers associated with critical medical domains. Its research and development activities for all IVD products: Biomarker Discovery and Validation, Assay Development, Validation - Clinical and Analytical and Platform Transfer. Its product AF-1200 Fluorescence Immunoassay Analyzer, AF-100 Fluorescence Immunoassay Analyzer, AF-100S Fluorescence Immunoassay Analyzer, AF-100C Fluorescence Immunoassay Analyzer.
Contact
Wilhelm Gutbrod Str 21B
Frankfurt am Main60437
DEUT: +49 16096247281
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,195.50 | 10.00 | 0.12% |
| CAC 40 | 7,935.74 | 54.37 | -0.68% |
| DAX 40 | 22,491.49 | 187.25 | -0.83% |
| Dow JONES (US) | 42,299.70 | 155.09 | -0.37% |
| FTSE 100 | 8,655.68 | 10.44 | -0.12% |
| HKSE | 23,426.60 | 152.20 | -0.65% |
| NASDAQ | 17,804.03 | 94.98 | -0.53% |
| Nikkei 225 | 37,120.33 | 679.64 | -1.80% |
| NZX 50 Index | 12,287.46 | 18.33 | -0.15% |
| S&P 500 | 5,693.31 | 18.89 | -0.33% |
| S&P/ASX 200 | 7,982.00 | 13.00 | 0.16% |
| SSE Composite Index | 3,351.31 | 22.44 | -0.67% |